Drug Trial Radar · NCT03492177
A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
63
Actual
Start
Jul 23, 2018
Primary completion
Mar 28, 2022
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- ActelionJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Apr 10, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study to confirm the selexipag starting dose(s), selected based on pharmacokinetic (PK) extrapolation from adults, that leads to similar exposure as adults doses in children from greater than or equal to (\>=) 2 to less than (˂) 18 years of age with Pulmonary Arterial Hypertension (PAH), by investigating the PK of selexipag and its active metabolite ACT-333679 in this population.
Conditions
- Pulmonary Arterial Hypertension
Interventions
selexipag (Uptravi)Drug
Film-coated tablets for oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area Under the Plasma Concentration-time Curve Over a Dose Interval at Steady State of Selexipag and Its Metabolite ACT-333679 Combined (AUCτ, ss, Combined)Time frame: Week 1,Week 12: pre-dose, 1, 2, 4, 6, 8 and 12 h post-morning dose. Week 2, 4 and 6: pre-dose (Up to Week 12)
Locations
34 sites in 16 countries. Site status is shown where the registry gives one.
Children'S Hospital Cardiac Care Center University Of Colorado
Aurora, Colorado
University of Iowa Hospital
Iowa City, Iowa
Seattle Children's Hospital
Seattle, Washington
State Institution Republican Scientific And Practical Center For Pediatric Surgery
Minsk, Belarus
Health Institution 4Th City Children'S Clinical Hospital
Minsk, Belarus
UZ Gent
Ghent, Belgium
Centre Hospitalier Sainte Justine
Montreal, Quebec, Canada
Beijing Anzhen Hospital
Beijing, China
Shanghai Childrens Medical Center
Shanghai, China
CHU Arnaud de Villeneuve
Montpellier, France
Hôpital Necker - Enfants Malades
Paris, France
Chu Hopital Des Enfants
Toulouse, France
Universitätsklinikum Freiburg Zentrum
Freiburg im Breisgau, Germany
Gottsegen Gyorgy Orszagos Kardiologiai Intezet, Felnott kardiologiai osztaly
Budapest, Hungary
Schneider Children's Medical Center
Petach Tikvah, Israel
Sheba Medical Center
Ramat Gan, Israel
Sarawak Heart Center
Kota Samarahan, Malaysia
Institut Jantung Negara (National Heart Institute)
Kuala Lumpur, Malaysia
Wojewodzki Szpital Specjalistyczny We Wroclawiu
Wroclaw, Poland
Kazan State Medical University
Kazan', Russia
Scientific and Research Institution of Cardiovascular Diseases Complex Problems
Kemerovo, Russia
Moscow Scientific Research Institute For Pediatrics And Childrens Surgery Of Rosmedtechnologies
Moscow, Russia
Saint Petersburg State Pediatric Medical University
Saint Petersburg, Russia
Almazov National Medical Research Center Of The Ministry Of Health Of The Russian Federation
Saint Petersburg, Russia
Samara Regional Clinical Cardiological Dispensary
Samara, Russia
Univerzitetska Dečja Klinika
Belgrade, Serbia
Institut Za Zdravstvenu Zastitu Majke I Deteta Srbije Dr Vukan Cupic
Belgrade, Serbia
National Cheng Kung University Hospital
Tainan, Taiwan
National Taiwan University Hospital
Taipei, Taiwan
Municipal Enterprise Of The Dnipropetrovsk Regional Council
Dnipro, Ukraine
State Institution Of The Ministry Of Health Of Ukraine
Kiev, Ukraine
Lviv Regional Clinical Hospital
Lviv, Ukraine
Municipal Institution Of The Zaporizhzhya Regional Council
Zaporizhzhya, Ukraine
Great Ormond Street Hospital
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.